癌診療指針のための病理診断プラクティス　内分泌腫瘍　甲状腺、副腎

出版社： 中山書店
著者：
発行日： 2018-07-10
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784521742717
シリーズ： 癌診療指針のための病理診断プラクティス
電子書籍版： 2018-07-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

23,100 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

23,100 円(税込)

購入する

商品紹介

実際的かつ標準的な病理学の知識を簡潔な文章と豊富な病理写真，診断フローチャートで解説する『病理診断プラクティス』シリーズ．「内分泌腫瘍」の巻では，甲状腺と副腎の二つの臓器を中心に，現在の病理診断のスタンダードを示す．最新のWHO分類に基づき，多様な内分泌疾患の病理に迫る．甲状腺検査の機会が増える超音波技師にもお勧め．

目次

  • 表紙
  • 刊行にあたって
  • 序
  • Contents
  • 執筆者一覧
  • ( 甲状腺・副甲状腺 )
  • 1章 病理診断の流れとポイント
  • 甲状腺と副甲状腺疾患の病理診断
  • 2章 診断のための基本知識
  • 病理診断の参考事項
  • 甲状腺・副甲状腺疾患の血清学的診断
  • 甲状腺・副甲状腺画像診断
  • 甲状腺の細胞診
  • 甲状腺癌の広がり - TNM 分類
  • 甲状腺微小癌の診断と取り扱い
  • 術中病理診断の意義
  • 甲状腺腫瘍の遺伝子異常と診断応用
  • 甲状腺・副甲状腺疾患の治療
  • 外科的治療
  • 甲状腺癌ホルモン療法
  • 甲状腺癌放射線療法
  • 甲状腺癌の薬物療法
  • 3章 甲状腺・副甲状腺疾患の概要と鑑別診断
  • 甲状腺非腫瘍性および腫瘍性疾患
  • 腺腫様甲状腺腫
  • 濾胞腺腫
  • 硝子化索状腫瘍
  • 境界悪性腫瘍
  • 甲状腺悪性腫瘍
  • 乳頭癌
  • 濾胞癌
  • 髄様癌
  • 低分化癌
  • 甲状腺未分化癌
  • 甲状腺リンパ腫
  • その他, まれな原発性腫瘍
  • 小児甲状腺癌
  • 4章 副甲状腺非腫瘍性および腫瘍性疾患の概要と鑑別診断
  • 副甲状腺過形成病変
  • 副甲状腺腺腫
  • 副甲状腺癌
  • その他の副甲状腺疾患
  • 5章 病理検体の取り扱い
  • 甲状腺病理標本の取り扱い方
  • 6章 症例の実際
  • 症例1 結節性病変をきたした IgG4 関連病変
  • 症例2 篩型乳頭癌
  • 症例3 異型間質細胞がびまん性に腫瘍間質に浸潤した低分化癌
  • 症例4 長期生存未分化癌
  • 症例5 CASTLE / ITET
  • 症例6 腎癌の腺腫様甲状腺腫内転移
  • 症例7 副甲状腺疾患
  • ( 副腎 )
  • 1章 病理診断の流れとポイント
  • 副腎疾患の病理診断の流れとポイント
  • 臨床から病理に期待すること
  • 2章 診断のための基本知識
  • 副腎皮質疾患の血清学的診断
  • 褐色細胞腫・パラガングリオーマの生化学的診断
  • 副腎疾患の遺伝的背景
  • 副腎疾患の画像診断
  • 細胞診, 免疫染色, 術中迅速診の有効性と限界
  • 副腎腫瘍の TNM 分類
  • 副腎皮質癌の治療
  • 褐色細胞腫の薬物療法
  • 3章 副腎皮質疾患の概要と鑑別診断
  • 鑑別が問題になる特殊亜型の腫瘍
  • Cushing' s adenoma
  • 副腎皮質癌粘液亜型, 粘液型副腎皮質癌
  • オンコサイトーマ
  • 悪性腫瘍
  • 副腎皮質癌
  • 転移性 ( 二次性 ) 副腎腫瘍
  • 4章 副腎髄質疾患の概要と鑑別診断
  • 神経節細胞腫と関連疾患
  • 褐色細胞腫
  • 副腎外パラガングリオーマ
  • MEN と副腎髄質病変
  • 5章 病理検体の取り扱い
  • 副腎皮質疾患
  • 副腎髄質疾患
  • 6章 症例の実際
  • 症例1 黒色腺腫, 色素性腺腫
  • 症例2 小児副腎皮質癌
  • 参考文献
  • 索引
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

( 甲状腺・副甲状腺 )

P.4 掲載の参考文献
加藤良平. 甲状腺. 病理と臨床 2017 ; 35 : 362-70.
 
Guerra G, et al. Morphological, diagnostic and surgical features of ectopic thyroid gland : a review of literature. Int J Surg 2014 : 12 : S3-S11.
PubMed
日本甲状腺学会編. 甲状腺結節取扱い診療ガイドライン 2013. 東京 : 南江堂 ; 2013.
 
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
亀山香織. 副甲状腺. 病理と臨床 2017 ; 35 : 371-6.
 
亀山香織. 副甲状腺. 腫瘍病理鑑別診断アトラス NET・下垂体・副甲状腺・副腎. 笹野公伸ほか編. 東京 : 文光堂 ; 2017. p.170-91.
 
P.18 掲載の参考文献
日本甲状腺学会. 甲状腺疾患診断ガイドライン 2013. http://www.japanthyroid.jp/doctor/guideline/japanese.html
 
玉井秀一. 甲状腺検査値の読み方. 宮内昭監, 網野信行編. 甲状腺疾患の疾病管理テキスト. 第2版. 大阪 : メディカルレビュー社 ; 2012. p.2-6.
 
宮内昭監, 網野信行編. 甲状腺・副甲状腺診療ゴールデンハンドブック. 東京 : 南江堂 ; 2012.
 
竹内靖博. 高カルシウム血症 鑑別診断. 日内会誌 2007 ; 96 : 656-61.
 
Fukumoto S, et al. Causes and differential diagnosis of hypocalcemia : recommendation proposed by expert panel supported by ministry of health, labour and welfare, Japan. Endocr J 2008 ; 55 : 787-94.
 
P.23 掲載の参考文献
日本乳腺甲状腺超音波医学会, 甲状腺用語診断基準委員会編. 甲状腺超音波診断ガイドブック. 改訂第3版. 東京 : 南江堂 ; 2016.
 
日本超音波医学会用語・診断基準委員会. 甲状腺結節 (腫瘤) 超音波診断基準. JPN J Med Ultrasonics 2011 ; 38 : 667-8.
 
鈴木眞一. 一般医のためのエコー活用法 甲状腺. Medicina 2007 ; 44 : 412-22.
 
眞一. 甲状腺エラストグラフィー. 臨床画像 2011 ; 27 (増刊) : 92-7.
 
P.33 掲載の参考文献
日本臨床細胞学会編. 細胞診ガイドライン 3 甲状腺・内分泌・神経系 2015年版. 東京 : 金原出版 ; 2015.
 
日本甲状腺外科学会編. 甲状腺癌取扱い規約. 第7版. 東京 : 金原出版 ; 2015.
 
社本幹博監. 新版 細胞診断学入門. 名古屋 : 名古屋大学出版会 ; 2009.
 
坂本穆彦監訳. 甲状腺細胞診ベセスダシステム. 東京 : シュプリンガー・ジャパン ; 2011.
 
越川卓. 細胞診文献シリーズ No.19. メイ・ギムザ染色を主体とした甲状腺の細胞診. 東京 : 武藤化学薬品 ; 1991.
 
Orell SR, et al. Manual and Atlas of Fine Needle Aspiration Cytology. 4th ed. London : Churchill-Livingstone ; 1999.
 
Orell SR, Philips J. Monographs in Clinical Cytology. Vol 14. The Thyroid. Fine Needle Biopsy and Cytological Diagnosis of Thyroid Lesions. Basel : Karger ; 1997.
 
Kini SR. Guides to clinical aspiration biopsy. Thyroid. New York : Igaku-shoin ; 1987.
 
Drose, M. Aspirationszytologie der Schilddruse. Stuttgart : FK Schattauer ; 1979.
 
P.52 掲載の参考文献
日本甲状腺外科学会編. 甲状腺癌取扱い規約. 第7版. 東京 : 金原出版 ; 2015.
 
Lloyd RV, et al., eds. WHO Classification of Tumours Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
Mete O, et al. Controversies in thyroid pathology : thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 2010 ; 17 : 386-91.
PubMed
P.56 掲載の参考文献
Takebe K, et al. Mass screening for thyroid cancer with ultrasonography [in Japanese]. KARKINOS 1994 ; 7 : 309-17.
 
Takami H, et al. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 2011 ; 35 : 111-21.
PubMed
Haugen BR, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016 ; 26 : 1-133.
PubMed
日本乳腺甲状腺超音波医学会 甲状腺用語診断基準委員会編. 甲状腺超音波診断ガイドブック. 改訂第3版. 東京 : 南江堂 ; 2016.
 
Ito Y, et al. Revisiting low-risk thyroid papillary microcarcinomas resected without observation : Was immediate surgery necessary? World J Surg 2016 ; 40 : 523-8.
PubMed
Ito Y, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014 ; 24 : 27-34.
 
Sugitani I, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized : our treatment strategies and outcomes. World J Surg 2010 ; 34 : 1222-31.
PubMed
P.63 掲載の参考文献
Anton RC, Wheeler TM. Frozen section of thyroid and parathyroid specimens. Arch Pathol Lab Med 2005 ; 129 : 1575-84.
PubMed
Huber GF, et al. Intraoperative frozen-section analysis for thyroid nodules : a step toward clarity or confusion? Arch Otolarygol Head Nech Surg 2007 ; 133 : 874-81.
PubMed
Haymart MR, et al. The role of intraoperative frozen section if suspicious for papillary thyroid cancer. Thyroid 2008 ; 18 : 419-23.
PubMed
杉野公則ほか. 甲状腺・副甲状腺手術における術中迅速PTH測定の有用性. 日内分泌・甲状腺外会誌 2013 ; 30 : 201-6.
 
P.67 掲載の参考文献
日本甲状腺外科学会編. 甲状腺癌取扱い規約. 第7版. 東京 : 金原出版 ; 2015.
 
Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009 ; 132 : 658-65.
PubMed
Williams ED. Guest editorial : two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 2000 ; 8 : 181-3.
PubMed
Nikiforov YE, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma. A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2016 ; 2 : 1023-9.
PubMed
Kondo T, et al. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006 ; 6 : 292-306.
PubMed
Vuong HG, et al. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time : a systemic review. Oncotarget 2017 ; 8 : 10637-49.
 
P.73 掲載の参考文献
日本甲状腺外科学会編. 甲状腺癌取扱規約. 第7版. 東京 : 金原出版 ; 2015.
 
鈴木眞一. 甲状腺良性結節. 村井勝, 高見博編. 内分泌外科標準テキスト. 東京 : 医学書院 ; 2003. p.47-52.
 
日本内分泌外科学会, 日本甲状腺外科学会編. 甲状腺腫瘍診療ガイドライン. 2010年版. 東京 : 金原出版 ; 2010.
 
鈴木眞一ほか. 甲状腺癌の外科治療. 癌と化療 2015 ; 42 : 661-5.
 
鈴木眞一. 内視鏡下バセドウ病手術. 伴良雄編. よくわかる甲状腺疾患のすべて. 改訂第2版. 大阪 : 永井書店 ; 2009. p.218-25.
 
Bilezikian JP, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism : summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014 ; 10 : 3561-9.
PubMed
Suzuki S, et al. Video-assisted parathyroidectomy. Biomed Pharmacother 2002 ; 56 Suppl 1 : 18s-21s.
 
鈴木眞一. 原発性副甲状腺機能亢進症の手術 (腺腫・過形成・癌). 日本内分泌外科学会編. 内分泌外科標準手術アトラス. 改訂版. 東京 : インターメルク ; 2003. p.167-74.
 
鈴木眞一. 術中ラジオガイド法による副甲状腺摘除. 内分泌外科の要点と盲点 改訂版. 東京 : 文光堂 ; 2007. p.221-3.
 
冨永義博. 二次性副甲状腺機能亢進症の治療. 冨永義博編. 副甲状腺機能亢進症の外科. 東京 : 東京医学社 ; 2016. p.54-138.
 
P.80 掲載の参考文献
Mazzaferri EL, Kloos RT. Clinical review 128 : Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinl Metab 2001 ; 86 : 1447-63.
 
McGriff NJ, et al. Effects of thyroid suppression therapy on adverth clinical outcomes in thyroid cancer. Ann Med 2002 ; 34 : 554-64.
 
Jonklaas J, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006 ; 16 : 1229-42.
PubMed
Sugitani I, Fujimoto Y. Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. J Clin Endocrinol Metab 2010 ; 95 : 4576-83.
PubMed
Carhill AA, et al. Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma : NTCTCS Registry Analysis 1987-2012. J Clin Endocrinol Metab 2015 ; 100 : 3270-9.
PubMed
Heemstra KA, et al. The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. Thyroid 2006 ; 16 : 583-91.
 
Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016 ; 26 : 1-133.
PubMed
日本内分泌外科学会, 日本甲状腺外科学会編. 甲状腺腫瘍診療ガイドライン 2010年版. 東京 : 金原出版 ; 2010.
 
Ito M, et al. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur J Endocrinol 2012 ; 167 : 373-8.
PubMed
Ito M, et al. Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy. Thyroid 2017 ; 27 : 484-90.
PubMed
P.83 掲載の参考文献
日本核医学会分科会 腫瘍・免疫核医学研究会, 甲状腺RI治療委員会. 甲状腺癌の放射性ヨード内用療法に関するガイドライン. 第5版. http://oncology.jsnm.org/files/pdf/thyroid-guideline_201408.pdf
 
日本内分泌外科学会, 日本甲状腺外科学会編. 甲状腺腫瘍診療ガイドライン 2010 年版. 東京 : 金原出版 ; 2010.
 
Mazzaferri EL, Kloos RT. Clinical review 128 : current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001 ; 86 : 1447-63.
PubMed
Sisson JC, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. Thyroid 2011 ; 21 : 335-46.
PubMed
横山邦彦ほか. 甲状腺癌に対する放射性ヨード内用療法-治療効果のエビデンスと日本における問題点. 外科 2006 ; 68 : 773-6.
 
茂松直之. 甲状腺疾患に対する放射線外照射. 日臨 2007 ; 65 : 2053-60.
 
絹谷清剛. 甲状腺分化癌再発に対する内用療法原則論. 日内分泌・甲状腺外会誌 2012 ; 29 : 268-74.
 
絹谷清剛. 甲状腺癌の内照射と外照射. CLINICIAN 2017 ; 655 : 211-5.
 
P.86 掲載の参考文献
Brose MS, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer : a randomised, double-blind, phase 3 trial. Lancet 2014 ; 384 : 319-28.
 
Schlumberger M, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 2015 ; 372 : 621-30.
PubMed
Ren Z, et al. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol 2015 ; 33 : 894-900.
PubMed
Wells SA, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer : a randomized, double-blind phase III trial. J Clin Oncol 2012 ; 30 : 134-41.
 
Ito Y, et al. Sorafenib in Japanese patients with locally advanced or metastatic medullary thyroid carcinoma and anaplastic thyroid carcinoma. Thyroid 2017 ; 27 : 1142-8.
PubMed
Elisei R, et al. Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol 2013 ; 31 : 3639-46.
PubMed
Onoda N, et al. The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients : A Nationwide Prospective Study. Thyroid 2016 ; 26 : 1293-9.
PubMed
Tahara M, et al. Lenvatinib for anaplastic thyroid cancer. Front Oncol 2017 ; 7 : 25.
PubMed
P.92 掲載の参考文献
Sendt W, et al. Monosomy and ring chromosome 13 in a thyroid nodular goiter-do we underestimate its relevance in benign thyroid lesions? Cancer Genet 2012 ; 205 : 128-30.
 
Rio Frio T, et al. DICER1 mutations in familial multinodular goiter with or without ovarian Sertoli-Leydig cell tumors. JAMA 2011 ; 305 : 68-77.
PubMed
P.99 掲載の参考文献
Williams ED. Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 2000 ; 8 : 181-3.
PubMed
Nikiforov YE, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma : A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2016 ; 2 : 1023-9.
PubMed
Takada N, et al. Diagnostic value of GATA-3 in cytological identification of parathyroid tissues. Endocr J 2016 ; 63 : 621-6.
PubMed
P.110 掲載の参考文献
Kakudo K, et al. Encapsulated papillary thyroid carcinoma, follicular variant : a misnomer. Pathol Int 2012 ; 62 : 155-60.
PubMed
Hirokawa M, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 2002 ; 26 : 1508-14.
PubMed
Nikiforov YE, et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma : A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol 2016 ; 2 : 1023-9.
PubMed
Liu Z, et al. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential : a morphological, immunohistochemical, and molecular appraisal. Cancer Sci 2011 ; 102 : 288-94.
PubMed
Bychkov A, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Thyroid 2017 ; 27 : 983-4.
PubMed
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs (4th ed). IARC : Lyon ; 2017.
 
Yang GC, et al. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma. Diagn Cytopathol 2017 [Epub ahead of print].
PubMed
Cho U, et al. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma : the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol 2017 ; 30 : 810-25. [Epub ahead of print].
 
Gucer H, et al. The value of HBME-1 and claudin-1 expression profile in the distinction of BRAF-like and RAS-like phenotypes in papillary thyroid carcinoma. Endocr Pathol 2016 ; 27 : 224-32.
PubMed
Piana S, et al. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol 2010 ; 34 : 868-72.
 
Bai Y, et al. Subclassification of non-solid-type papillary thyroid carcinoma, identification of high-risk group in common type. Cancer Sci 2008 ; 99 : 1908-15.
PubMed
Bychkov A, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice : perspectives for surgical pathology and cytopathology. Endocr Pathol 2018 [Epub ahead of print].
 
Kakudo K, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in thyroid tumor classification. Pathol Int 2018 [Epub ahead of print].
 
P.117 掲載の参考文献
日本甲状腺外科学会編. 甲状腺癌取扱い規約. 第7版. 東京 : 金原出版 ; 2015.
 
P.127 掲載の参考文献
Bartolazzi A, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001 ; 357 : 1644-50.
PubMed
Nikiforova MN, et al. PAX8-PPAR gamma rearrangement in thyroid tumors : RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002 ; 26 : 1016-23.
 
Nikiforova MN, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors : evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003 ; 88 : 2318-26.
PubMed
Hunt JL, et al. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol 2003 ; 34 : 375-80.
PubMed
Prasad ML, et al. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 2005 ; 18 : 48-57.
PubMed
Ito Y, et al. Prognosis and prognostic factors of follicular carcinoma in Japan : importance of postoperative pathological examination. World J Surg 2007 ; 31 : 1417-24.
PubMed
Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 2013 ; 13 : 184-99.
PubMed
Hsiao SJ, Nikiforov YE. Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer 2014 ; 21 : T301-13.
PubMed
Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014 ; 159 : 676-90.
 
Dralle H, et al. Follicular cell-derived thyroid cancer. Nat Rev Dis Primers 2015 ; 1 : 15077.
PubMed
P.136 掲載の参考文献
Kameyama K, Takami H. Medullary thyroid carcinoma : Nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J 2004 ; 51 : 453-6.
PubMed
Kameyama K, et al. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Biomed Pharmacother 2004 ; 58 : 345-7.
PubMed
Takami H. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocr Pathol 2003 ; 14 : 123-31.
PubMed
P.144 掲載の参考文献
WHO Classification of Tumours of Endocrine Organs. WHO Health organization 3rd ed. Lyon : IARC press ; 2004.
 
WHO Classification of Tumours of Endocrine Organs. WHO Health organization 4th ed. Lyon : IARC press ; 2017.
 
日本甲状腺外科学会編. 甲状腺癌取扱い規約. 第7版. 東京 : 金原出版 ; 2015.
 
Kondo T, et al. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006 ; 6 : 292-306.
PubMed
Sakamoto A, et al. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983 ; 52 : 1849-55.
PubMed
Carcangiu ML, et al. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol 1984 ; 8 : 655-68.
PubMed
Volante M, et al. Poorly differentiated thyroid carcinoma : the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007 ; 31 : 1256-64.
 
Dettmer M, et al. Poorly differentiated oncocytic thyroid carcinoma-diagnostic implications and outcome. Histopathology 2012 ; 60 : 1045-51.
PubMed
Nishida T, et al. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 1999 ; 23 : 205-11.
PubMed
P.150 掲載の参考文献
廣川満良. 甲状腺腫瘍の最近のトピックス. 甲状腺未分化癌の病理-診断における問題点-. 病理と臨 2013 ; 31 : 44-9.
 
菅間博, 亀山香織. 甲状腺の細胞診の新しい報告様式と技術によせて. 甲状腺腫瘍の遺伝子診断と細胞診. 日内分泌・甲状腺外会誌 2014 ; 31 : 98.
 
日本甲状腺外科学会編. 甲状腺癌取扱い規約. 第7版. 東京 : 金原出版 ; 2015.
 
Lloyd RV, et al., eds. World Health Organization Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
Smallridge RC, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2012 : 22 : 1104-39.
PubMed
P.157 掲載の参考文献
Kato I, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985 ; 76 : 1085-90.
PubMed
Rosai J, et al. Malignant lymphoma of the thyroid gland and related lesions. In : Rosai J, et al. editors. Tumors of the Thyroid and Parathyroid Glands. AFIP atlas of tumor pathology series 4. Silver Spring Maryland : American Registory of Pathology ; 2014. p.299-307.
 
Rosai J, et al. Thyroiditis Hashimoto thyroiditis. In : Rosai J, et al. editors. Malignant lymphoma of the thyroid gland and related lesions. AFIP atlas of tumor pathology series 4. Silver Spring Maryland : American Regstory of Pathology ; 2014. p.339-42.
 
Chan JKC, et al. Primary thyroid lymphoma. In : Lloyd RV, et al. editors. WHO classification of Tumour of Endocrine Organs. 4th ed. Lyon : International Agency for Research on Cancer ; 2017. p137-8.
 
Lloyd RV, et al. Hashimoto's thyroiditis. In : Lloyd RV, Douglas BR, Young, Jr WF editors. Endocrine Diseases. Atlas of nontumor pathology. First series Fascicle 1. Silver Spring Maryland : American Registry of Pathology and Washington DC : Armed Forces Institute of Pathology ; 2002. p.115-26.
 
Umehara H, et al. A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details. Mod Rheumatol 2012 ; 22 : 1-14.
PubMed
梅原久範. 日本からの発信 : 新たな疾患概念. IgG4関連疾患 (IgG4-related disease). 日内会誌 2010 ; 99 : 237-45.
 
P.176 掲載の参考文献
Bogdanova TI, et al. Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine. Endocr J 2017 ; 64 : 977-93. doi : 10.1507/endocrj. EJ17-0134. [Epub ahead of print]
 
Mitsutake N, et al. BRAF (V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima : a different oncogenic profile from Chernobyl. Scientific Reports 2015 ; 5 : 16976.
 
Bogdanova T, et al. Thyroid cancer pathology in Ukraine after Chernobyl. In : Thyroid cancer pathology in Ukraine after the Chernobyl-dosimetry, epidemiology, pathology, molecular biology, Tronko M, et al. editors. Nagasaki ; IN-TEX Ltd, 2014. p.65-108.
 
Fridman MV, et al. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Thyroid 2012 ; 22 : 1016-24.
PubMed
Tuttle RM, et al. Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers : what do we know now? What can we expect in the future? Clin Oncol (R Coll Radiol) 2011 ; 23 : 268-75.
PubMed
Williams ED, et al. Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid 2008 ; 18 : 847-52.
PubMed
Williams ED, et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer 2004 ; 90 : 2219-24.
PubMed
Shirahige Y, et al. Childhood thyroid cancer : comparison of Japan and Belarus. Endocr J 1998 ; 45 : 203-9.
PubMed
菅間博. 小児の甲状腺癌の病理組織学的な特徴, 特にびまん性硬化型乳頭癌に着目して. 日内分泌・甲状腺外会誌 2013 ; 30 : 281-6.
 
P.184 掲載の参考文献
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. World Health Organization. 4th ed. Lyon : IARC Press ; 2017.
 
DeLellis RA, et al. Primary hyperparathyroidism : a current perspective. Arch Pathol Lab Med 2008 ; 132 : 1251-62.
PubMed
Ordonez NG. Value of GATA3 immunostaining in tumor diagnosis : a review. Adv Anat Pathol 2013 ; 20 : 352-60.
PubMed
Tominaga Y, et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996 ; 20 : 744-50.
PubMed
P.188 掲載の参考文献
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
DeLellis RA, et al. Primary hyperparathyroidism : a current perspective. Arch Pathol Lab Med 2008 ; 132 : 1251-62.
PubMed
Ordonez NG. Value of GATA3 immunostaining in tumor diagnosis : a review. Adv Anat Pathol 2013 ; 20 : 352-60.
PubMed
Tominaga Y, et al. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 1999 ; 55 : 1375-83.
PubMed
P.192 掲載の参考文献
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 1973 ; 31 : 600-5.
PubMed
Carpten JD, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002 ; 32 : 676-80.
PubMed
Kumari N, et al. Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms. Endocr Pathol 2016 ; 27 : 87-96.
PubMed
P.196 掲載の参考文献
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
DeLellis RA, et al. Primary hyperparathyroidism : a current perspective. Arch Pathol Lab Med 2008 ; 132 : 1251- 62.
 
Ordonez NG. Value of GATA3 immunostaining in tumor diagnosis : a review. Adv Anat Pathol 2013 ; 20 : 352- 60.
 
P.202 掲載の参考文献
長沼廣ほか. バセドウ病甲状腺に合併した甲状腺癌の病理学的検討. 仙台市立病院医誌 1995 ; 15 : 3-8.
 
廣川満良ほか. 外科病理マニュアル 甲状腺・副甲状腺. 病理と臨床 2008 ; 26 : 232-7.
 
Yamashina M. Follicular neoplasms of the thyroid. Total circumferential evaluation of the fibrous capsule. Am J Surg Pathol 1992 ; 16 : 392-400.
PubMed
P.208 掲載の参考文献
Deshpande V, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012 ; 25 : 1181-92.
PubMed
Kamisawa T, et al. IgG4-related disease. Lancet 2015 ; 385 : 1460-71.
PubMed
Hirokawa M, et al. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis. Endocr J 2018 ; 26 : 175-80.
 
P.213 掲載の参考文献
廣川満良, 樋口観世子. 篩型乳頭癌. Thyroid Cancer Explore 2015 ; 1 : 82-6.
 
Hirokawa M, et al. Cribriform-morular variant of papillary thyroid carcinoma-cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol 2000 ; 38 : 890-6.
 
Ito Y, et al. Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma ; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J 2011 ; 58 : 685-9.
PubMed
P.218 掲載の参考文献
吉田明. State of the Art臨床 偶発型甲状腺未分化癌. Thyroid Cancer Explore 2016 ; 2 : 32-7.
 
田中克浩. 甲状腺未分化がんの生物学的特性と治療戦略. 最新医学 2013 ; 68 : 1862-6.
 
宍戸-原由紀子ほか. Breast carcinoma with osteoclast-like stromal giant cells-破骨細胞様間質巨細胞の出現と, 富血管性炎症性間質の関係とは?-. 病理と臨床 2015 ; 33 : 793-7.
 
P.222 掲載の参考文献
Higashiyama T, et al. Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid 2010 ; 20 : 7-14.
PubMed
Sugitani I, et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma : ATC Research Consortium of Japan cohort study of 677 patients. World J Surg 2012 ; 36 : 1247-54.
 
Hirokawa M, et al. Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival : A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan. Endocr J 2016 ; 63 : 441-7.
 
P.227 掲載の参考文献
Kakudo K, et al. Intrathyroid thymic carcinoma. In : Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC press ; 2017. p.125-6.
 
Miyauchi A, et al. Intrathyroidal epithelial thymoma : an entity distinct from squamous cell carcinoma of the thyroid. World J Surg 1985 ; 9 : 128-35.
PubMed
Chan JK, Rosai J. Tumors of the neck showing thymic or related branchial pouch differentiation : a unifying concept. Hum Pathol 1991 ; 22 : 349-67.
 
Dorfman DM, et al. Intrathyroidal epithelial thymoma (ITET) /carcinoma showing thymuslike differentiation (CASTLE) exhibits CD5 immunoreactivity : new evidence for thymic differentiation. Histopathology 1998 ; 32 : 104-9.
PubMed
Reimann JD, et al. Carcinoma showing thymus-like differentiation of the thyroid (CASTLE) : a comparative study : evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol 2006 ; 30 : 994-1001.
 
Ito Y, et al. Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation : a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol 2007 ; 127 : 230-6.
PubMed
Kakudo K, et al. Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymuslike differentiation (CASTLE) : CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid. Histol Histopathol 2013 ; 28 : 543-56.
PubMed
Hirokawa M, et al. Intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation ; comparison with thymic lymphoepithelioma-like carcinoma and a possibility of development from a multipotential stem cell. APMIS 2013 ; 121 : 523-30.
 
Wang YF, et al. Thyroid carcinoma showing thymus-like elements : a clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis. Am J Clin Pathol 2015 ; 143 : 223-33.
PubMed
P.231 掲載の参考文献
Suzuki A, et al. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma. Endocr J 2015 ; 62 : 991-5.
PubMed
Takada N, et al. Diagnostic value of GATA-3 in cytological identification of parathyroid tissues. Endocri J 2016 ; 63 : 621-6.
 
Kobayashi K, et al. Metastatic carcinoma to the thyroid gland from renal cell carcinoma : role of ultrasonography in preoperative diagnosis. Thyroid Res 2015 ; 8 : 4.
 
P.236 掲載の参考文献
Padgett SN, et al. Parathyroid hyperplasia of auto-transplanted tissue in forearm skin. J Cutan Pathol 2011 ; 38 : 232-5.
PubMed
Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 1973 ; 31 : 600-5.
PubMed
Lloyd RV, et al. Who Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
Block GA, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004 ; 350 : 1516-25.
PubMed
Sumida K, , et al. Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride. J Clin Pathol 2011 ; 64 : 756-60.
PubMed

( 副腎 )

P.242 掲載の参考文献
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
Yamazaki Y, et al. Histopathological classification of cross-sectional image-negative hyperaldosteronism. J Clin Endocrinol Metab 2017 ; 102 : 1182-92.
PubMed
P.249 掲載の参考文献
Plouin PF, et al. European Society of Endocrinology Clinical Practice Guideline for longterm follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 2016 ; 174 : G1-10.
PubMed
Niemeijer ND, et al. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma : systematic review and meta-analysis. Clin Endocrinol (Oxf) 2014 ; 81 : 642-51.
PubMed
Yoshinaga K, et al. Effects and safety of 131I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors : results from a multicenter observational registry. Endocr J 2014 ; 61 : 1171-80.
PubMed
Thompson LDR. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms : a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002 ; 26 : 551-66.
PubMed
Kimura N, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis : a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005 ; 16 : 23-32.
PubMed
Sabet FA, et al. Likelihood ratio of computed tomography characteristics for diagnosis of malignancy in adrenal incidentaloma : systematic review and meta-analysis. J Diabetes Metab Disorders 2016 ; 15 : 12.
 
Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984 ; 8 : 163-9.
PubMed
Aubert S, et al. Weiss system revisited : a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 2002 ; 26 : 1612-9.
PubMed
Pennanen M, et al. Helsinki score : a novel model for prediction of metastases in adrenocortical carcinomas. Hum Pathol 2015 ; 46 : 404-10.
 
Creemers SG, et al. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma. Endocr Relat Cancer 2016 ; 23 : R43-69.
PubMed
P.258 掲載の参考文献
柳瀬敏彦ほか. 日本内分泌学会臨床重要課題「潜在性クッシング症候群 (下垂体性と副腎) の診断基準の作成」. 日内分泌会誌 2017 ; 93 : 1-18.
 
成瀬光栄ほか. 日本内分泌学会臨床重要課題「わが国の原発性アルドステロン症の診療に関するコンセンサス・ステートメント」. 日内分泌会誌 2016 ; 92 : ii-49.
 
柳瀬敏彦ほか. 日本内分泌学会臨床重要課題「副腎クリーゼを含む副腎皮質機能低下症の診断と治療に関する指針」. 日内分泌会誌 2015 ; 91 : 1-4.
 
P.262 掲載の参考文献
厚生労働省難治性疾患克服研究事業「褐色細胞腫の実態調査と診療指針の作成」研究班 (研究代表者 成瀬光栄)・日本内分泌学会悪性褐色細胞腫検討委員会 (委員長成瀬光栄) 編. 褐色細胞腫診療指針 2012.
 
Lenders JW, et al. Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014 ; 99 : 1915-42.
PubMed
立木美香, 成瀬光栄. 褐色細胞腫/パラガングリオーマ. 成瀬光栄ほか編. 内分泌代謝専門医ガイドブック. 第4版. 東京 : 診断と治療社 ; 2016. p.269.
 
Eisenhofer G, et al. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma. Rev Endocr Metab Disord 2001 ; 2 : 297-311.
 
地曵和子ほか. 褐色細胞腫の診断におけるノルメタネフリンおよびメタネフリン測定の意義. 日内分泌誌 1998 ; 64 : 707-16.
 
Lenders JW, et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 1995 ; 123 : 101-9.
PubMed
Grouzmann E, et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol 2010 ; 162 : 951-60.
PubMed
Tanaka Y, et al. Plasma free metanephrines in the diagnosis of pheochromocytoma : diagnostic accuracy and strategies for Japanese patients. Endocr J 2014 ; 61 : 667-73.
PubMed
Peaston RT, et al. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin Chim Acta 2010 ; 411 : 546-52.
PubMed
Lenders JW, et al. Is supine rest necessary before blood sampling for plasma metanephrines? Clin Chem 2007 ; 53 : 352-4.
PubMed
Yu R, Wei M. False positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes 2010 ; 118 : 577-85.
PubMed
P.268 掲載の参考文献
Dahia PL. Pheochromocytoma and paraganglioma pathogenesis : learning from genetic heterogeneity. Nat Rev Cancer 2014 ; 14 : 108-19.
PubMed
Lenders JW, et al. Endocrine Society. Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014 ; 99 : 1915-42.
PubMed
Neumann HP, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004 ; 292 : 943-51.
PubMed
Benn DE, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006 ; 91 : 827-36.
PubMed
Brito JP, et al. Testing for germline mutations in sporadic pheochromocytoma/paraganglioma : a systematic review. Clin Endocrinol (Oxf) 2015 ; 82 : 338-45.
PubMed
Schiavi F, et al. Are we overestimating the penetrance of mutations in SDHB? Hum Mutat 2010 ; 31 : 761-2.
PubMed
Neumann HPH, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002 ; 346 : 1459-66.
PubMed
Curras-Freixes M, et al. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. J Med Genet 2015 ; 52 : 647-56.
PubMed
Rattenberry E, et al. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2013 ; 98 : E1248-56.
PubMed
P.276 掲載の参考文献
Omura M, et al. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006 ; 29 : 883-9.
PubMed
Boland GW, et al. Characterization of adrenal masses using unenhanced CT : an analysis of the CT literature. AJR Am J Roentgenol 1998 ; 171 : 201-4.
PubMed
Halefoglu AM, et al. Comparison of computed tomography histogram analysis and chemicalshift magnetic resonance imaging for adrenal mass characterization. Acta Radiol 2009 ; 50 : 1071-9.
PubMed
Caoili EM, et al. Adrenal masses : characterization with combined unenhanced and delayed enhanced CT. Radiology 2002 ; 222 : 629-33.
PubMed
Koopman D, et al. Current generation time-of-flight (18) F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands. Ann Nucl Med 2016 ; 30 : 145-52.
PubMed
Omura K, et al. Anatomical Variations of the Right Adrenal Vein : Concordance Between Multidetector Computed Tomography and Catheter Venography. Hypertension 2017 ; 69 : 428-34.
PubMed
Satani N, et al. Intra-adrenal Aldosterone Secretion : Segmental Adrenal Venous Sampling for Localization. Radiology 2016 ; 278 : 265-74.
PubMed
Burton TJ, et al. Evaluation of the sensitivity and specificity of (11) C-metomidate positron emission tomography (PET) -CT for lateralizing aldosterone secretion by Conn's adenomas. J Clin Endocrinol Metab 2012 ; 97 : 100-9.
 
Lingam RK, et al. CT of primary hyperaldosteronism (Conn's syndrome) : the value of measuring the adrenal gland. AJR Am J Roentgenol 2003 ; 181 : 843-9.
PubMed
Mantero F, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000 ; 85 : 637-44.
 
Shulkin BL, et al. Pheochromocytomas : imaging with 2- [fluorine-18] fluoro-2-deoxy-D-glucose PET. Radiology 1999 ; 212 : 35-41.
PubMed
P.293 掲載の参考文献
Brierley JD, et al., eds. Adrenal Cortex TNM Classification of Malignant Tumours, 8th ed. Oxford : John Wiley & Sons ; 2017. p.211-3.
 
中村保宏ほか. 病理学的事項. 日本泌尿器学会ほか編. 副腎腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2015. p.86-116.
 
Fassnacht M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma : proposal for a Revised TNM Classification. Cancer 2009 ; 115 : 243-50.
PubMed
Correa P, Chen VW. Endocrine gland cancer. Cancer 1995 ; 75 : 338-52.
PubMed
三浦徳宣ほか. 副腎皮質癌7例の臨床病理学的特徴と予後の検討. 日泌尿会誌 2014 ; 105 : 79-84.
 
P.296 掲載の参考文献
Fassnacht M, et al. Adrenocortical carcinoma : a clinician's update. Nat Rev Endocrinol 2011 ; 7 : 323-35.
PubMed
Berruti A, et al. Adrenal cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012 ; 23 (Suppl 7) : vii131-8.
 
Kerkhofs TM, et al. Developing treatment for adrenocortical carcinoma. Endocr Relat Cancer 2015 ; 22 : R325-38.
PubMed
JCOGホームページ http://www.jcog.jp/
 
Konda B, Kirschner LS. Novel targeted therapies in adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes 2016 ; 23 : 233-41.
PubMed
Fassnacht M, et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012 ; 366 : 2189-97.
PubMed
Stigliano A, et al. New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (Review). Oncol Rep 2017 ; 37 : 1301-11.
PubMed
Varghese J, Habra MA. Update on adrenocortical carcinoma management and future directions. Curr Opin Endocrinol Diabetes Obes 2017 ; 24 : 208-14.
PubMed
Przytulska J, et al. Current and emerging therapies for adrenocortical carcinoma : review. Adv Clin Exp Med 2015 ; 24 : 185-93.
PubMed
P.302 掲載の参考文献
野城孝夫. カテコラミンの生理作用. 成瀬光栄ほか編. 褐色細胞腫診療マニュアル. 改訂第2版. 東京 : 診断と治療社 ; 2012. p.6-7.
 
日本内分泌学会悪性褐色細胞腫検討委員会・厚生労働省難治性疾患克服研究事業「褐色細胞腫の実態調査と診療指針作成」研究班 (平成23年10月改訂).
 
柴田洋孝. 症状, スクリーニング, 機能検査. 成瀬光栄ほか編. 褐色細胞腫診療マニュアル改訂. 第2版. 東京 : 診断と治療社 ; 2012. p.64-9.
 
木村伯子. 病理診断と悪性度. 成瀬光栄ほか編. 褐色細胞腫診療マニュアル. 改訂第2版. 東京 : 診断と治療社 ; 2012. p.64-9.
 
渡辺みか. 悪性褐色細胞腫-副腎褐色細胞腫の悪性度について-. 内分泌甲状腺外会誌 2013 ; 30 : 41-4.
 
Young WF, Kebebew E. Treatment of pheochromocytoma in adults. www.uptodate.com (C) 2017 UpToDate(R)
 
立木美香ほか. 褐色細胞腫クリーゼの治療. 成瀬光栄ほか編. 褐色細胞腫診療マニュアル. 改訂第2版. 東京 : 診断と治療社 ; 2012. p.55-7.
 
田辺晶代. 悪性褐色細胞腫へのCVD治療. 内分泌甲状腺外会誌 2015 ; 32 : 34-8.
 
竹澤健太郎ほか. CVD療法および放射線治療が奏効したMalignant paragangliomaの1例. 泌尿紀要 2009 ; 55 : 691-4.
 
竹越一博, 川上康. 遺伝性褐色細胞腫・パラガングリオーマ症候群. 内分泌甲状腺外会誌 2012 ; 29 : 104-12.
 
Lenders JW, et al. Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014 ; 99 : 1915-42. doi : 10.1210/jc. 2014-1498.
 
P.310 掲載の参考文献
日本泌尿器科学会ほか編. 副腎腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2015.
 
Ronchi CL, et al. Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J Clin Endocrinol Metab 2016 ; 101 : 3526-38.
PubMed
Duan K, et al. Clinicopathological correlates of adrenal Cushing's syndrome. J Clin Pathol 2015 ; 68 : 175-86.
PubMed
笹野公伸. 副腎. 向井清ほか編. 外科病理学. 第4版. 東京 : 文光堂 ; 2006. p.817- 42.
 
P.315 掲載の参考文献
Papotti M, et al. Adrenocortical tumors with myxoid features : a distinct morphologic and phenotypical variant exhibiting malignant behavior. Am J Surg Pathol 2010 ; 34 : 973-83.
PubMed
Weissferdt A, et al. Myxoid adrenocortical carcinoma ; a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia. Am J Clin Pathol 2013 ; 139 : 780-6.
PubMed
Lloyd RV, et al., eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017.
 
P.319 掲載の参考文献
Nose V, et al., eds. Adrenal Gland. Diagnostic Pathology : Endocrine. Salt Lake City ; Amirsys Inc : 2012. p.28-49.
 
Sato N, et al. Case report : adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1. Endocr Pathol 2014 ; 25 : 410-5.
PubMed
中村保宏ほか. 病理学的事項. 日本泌尿器科学会ほか編. 副腎腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2015. p.86-116.
 
中村保宏. 良性腫瘍. 笹野公伸ほか編. 腫瘍病理鑑別診断アトラス NET・下垂体・副甲状腺・副腎. 東京 : 文光堂 ; 2017. p.219-28.
 
Bisceglia M, et al. Adrenocortical oncocytic tumors : report of 10 cases and review of the literature. Int J Surg Pathol 2004 ; 12 : 231-43.
PubMed
Bisceglia M, et al. Oncocytic adrenocortical tumors. Pathol Case Rev 2005 ; 10 : 228-42.
 
P.342 掲載の参考文献
Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol 2017 ; 28 : 213-27.
PubMed
Maciel CA, et al. Imaging of rare medullary adrenal tumours in adults. Clin Radiol 2016 ; 71 : 484-94.
PubMed
吉田栄宏ほか. 副腎神経節細胞腫の1例. 泌尿器科紀要 2005 ; 51 : 93-6.
 
Ohtsuki Y, et al. Composite paraganglioma and ganglioneuroma in the retroperitoneum : a case report. Med Mol Morphol 2012 ; 45 : 168-72.
PubMed
Brady S, et al. Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A : case report with immunohistochemical analysis. Am J Surg Pathol 1997 ; 21 : 102-8.
PubMed
Warren M, et al. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients. Histopathology 2018 ; 72 : 685-96.
PubMed
P.348 掲載の参考文献
Kimura N, et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 2014 ; 21 : 405-14.
PubMed
Lenders JWM, et al. Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014 ; 99 : 1915-42.
PubMed
成瀬光栄ほか. 褐色細胞腫・悪性褐色細胞腫の診断基準. 成瀬光栄ほか編. 褐色細胞腫診療マニュアル. 改定第2版. 東京 : 診断と治療社 ; 2012. p.26-7.
 
Tischler AS, et al. Phaeochromocytoma. In : Lloyd RV, et al, eds. WHO Classification of Tumors of Endocrine Organs. 4th ed. Lyon : IARC Press ; 2017. p.183-9.
 
Thompson LD. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms : a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002 ; 26 : 551-66.
PubMed
Kimura N, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis : a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005 ; 16 : 23-32.
PubMed
Gimenez-Roqueplo AP, et al. Mutations in the SDHB gene associated with extra-adrenal and/or malignant pheochromocytomas. Cancer Res 2003 ; 63 : 5615-21.
 
van Nederveen FH, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations : a retrospective and prospective analysis. Lancet Oncol 2009 ; 10 : 764-71.
 
Burnichon N, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocri Metab 2009 ; 94 : 2817-27.
 
Kimura N, et al. Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 2014 ; 21 : L13-6.
PubMed
日本内分泌学会臨床重要課題「悪性褐色細胞腫の実態調査と診療指針の作製」検討委員会編「褐色細胞腫・パラガングリオーマ診療ガイドライン 2018」診断と治療社 (in print).
 
P.357 掲載の参考文献
Kimura N, et al. Paraganglion tumours. In : El-Naggar AD, et al, eds. WHO Classification of Head and Neck Tumours. Lyon : IARC Press ; 2017. p.275-84.
 
Kimura N, et al. Extraadrenal paraganglioma. In : Lloyd RV, et al, editors. WHO Classification of Tumours of Endocrine Organs. Lyon : IARC Press ; 2017. p.190-5.
 
Kimura N. Update on Tumors of Adrenal Medulla and Extra-adrenal Paraganglia. ASJP : Reviews & Reports 2017 ; 22 : 240-5.
 
Lenders JWM, et al. Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014 ; 99 : 1915?42.
 
成瀬光栄ほか. 褐色細胞腫・悪性褐色細胞腫の診断基準. 成瀬光栄ほか編. 褐色細胞腫診療マニュアル改定第2版. 東京 : 診断と治療社 ; 2012. p.26-7.
 
P.363 掲載の参考文献
多発性内分泌腫瘍ガイドブック編集委員会編. 多発性内分泌腫瘍症診療ガイドブック. 東京 : 金原出版 ; 2013.
 
Imai T, et al. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. Eur J Endocrinol 2013 ; 168 : 683-7.
PubMed
Rodriguez JM, et al. Pheochromocytoma in MEN 2A syndrome. Study of 54 patients. World J Surg 2008 : 32 : 2520-6.
PubMed
Mannelli M, et al. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 2009 ; 94 : 1541-7.
 
Eisenhofer G, et al. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab 2011 ; 96 : 375-84.
PubMed
Brandi ML, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001 ; 86 : 5658-71.
PubMed
Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms : a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002 ; 26 : 551-6.
PubMed
P.368 掲載の参考文献
中村保宏ほか. 病理学的事項. 日本泌尿器科学会ほか編. 副腎腫瘍取扱い規約. 第3版. 東京 ; 金原出版 : 2015. p.86-116.
 
笹野公伸ほか. 6. 副腎皮質 第1部 検鏡前の確認事項. 笹野公伸, 亀山香織編. 腫瘍病理鑑別診断アトラス NET・下垂体・副甲状腺・副腎. 東京 ; 文光堂 : 2017. p.200-9.
 
P.370 掲載の参考文献
Symington T. Adult adrenal cortex. In : Symington T, et al. eds. Functional Pathology of the Human Adrenal Gland. Livingstone, 1969. p.13-4.
 
日本泌尿器科学会ほか編. 副腎腫瘍取扱い規約. 第2版. 東京 : 金原出版 ; 2005. p.62.
 
P.374 掲載の参考文献
Visser JW, et al. A functioning black adenoma of the adrenal cortex : a clinico-pathological entity. J Clin Pathol 1974 ; 27 : 955-9.
PubMed
Tokunaga H, et al. Preclinical Cushing's syndrome resulting from black adrenal adenoma. A case report. Horm Res 2004 ; 62 : 60-6.
 
Erem C, et al. Adrenal black adenoma associated with Cushing's syndrome. Endocrine 2004 ; 25 : 253-7.
PubMed
P.377 掲載の参考文献
Wieneke JA, et al. Adrenal cortical neoplasms in the pediatric population : a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 2003 ; 27 : 867-81.
PubMed
Wasserman JD, et al. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma : a children's oncology group study. J Clin Oncol 2015 ; 33 : 602-9.
 
Das S, et al. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors : Is there a correlation? J Pediatr Surg 2016 ; 51 : 1795-800.
 
Michalkiewicz E, et al. Clinical and outcome characteristics of children with adrenocortical tumors : a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004 ; 22 : 838-45.
PubMed

書評

最近チェックした商品履歴

Loading...